van Besien K - Search Results

1

Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?

Liu H, van Besien K. Liu H, et al. Among authors: van besien k. Curr Hematol Malig Rep. 2015 Mar;10(1):1-7. doi: 10.1007/s11899-014-0245-y. Curr Hematol Malig Rep. 2015. PMID: 25667129 Review.

2

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.

van Besien K, Bartholomew A, Stock W, Peace D, Devine S, Sher D, Sosman J, Chen YH, Koshy M, Hoffman R. van Besien K, et al. Bone Marrow Transplant. 2000 Aug;26(4):445-9. doi: 10.1038/sj.bmt.1702518. Bone Marrow Transplant. 2000. PMID: 10982293

3

Autologous and allogeneic transplantation for aggressive NHL.

Smith SM, Grinblatt D, van Besien K. Smith SM, et al. Among authors: van besien k. Cytotherapy. 2002;4(3):223-40. doi: 10.1080/146532402320219745. Cytotherapy. 2002. PMID: 12194719 Review.

4

Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.

van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M, Maynard V, Stock W, Peace D, Ravandi F, Chen YH, Cheung T, Vijayakumar S, Hoffman R, Sosman J. van Besien K, et al. Bone Marrow Transplant. 2003 Jul;32(1):9-13. doi: 10.1038/sj.bmt.1704088. Bone Marrow Transplant. 2003. PMID: 12815472 Clinical Trial.

5

Van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M, Maynard V, Stock W, Peace D, Ravandi F, Chen YH, Hoffman R, Sossman J. Van Besien K, et al. Bone Marrow Transplant. 2003 Sep;32(5):471-6. doi: 10.1038/sj.bmt.1704166. Bone Marrow Transplant. 2003. PMID: 12942092 Clinical Trial.

6

Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.

Kebriaei P, Kline J, Stock W, Kasza K, Le Beau MM, Larson RA, van Besien K. Kebriaei P, et al. Among authors: van besien k. Bone Marrow Transplant. 2005 May;35(10):965-70. doi: 10.1038/sj.bmt.1704938. Bone Marrow Transplant. 2005. PMID: 15806131

7

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.

van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L, Jones D, Del Cerro P, Bennett D, Casey B, Odenike O, Thirman M, Daugherty C, Wickrema A, Zimmerman T, Larson RA, Stock W. van Besien K, et al. J Clin Oncol. 2005 Aug 20;23(24):5728-38. doi: 10.1200/JCO.2005.15.602. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009946 Clinical Trial.

8

Hematopoietic stem cell transplantation for myelofibrosis.

van Besien K, Deeg HJ. van Besien K, et al. Semin Oncol. 2005 Aug;32(4):414-21. doi: 10.1053/j.seminoncol.2005.04.013. Semin Oncol. 2005. PMID: 16202687 Review.

9

Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.

Artz AS, Kocherginsky M, Van Besien K. Artz AS, et al. Among authors: van besien k. Br J Haematol. 2006 Mar;132(6):747-54. doi: 10.1111/j.1365-2141.2005.05923.x. Br J Haematol. 2006. PMID: 16487176 Free article. Review.

10

Standardizing chronic graft-versus-host disease.

van Besien K. van Besien K. Future Oncol. 2006 Aug;2(4):459-62. doi: 10.2217/14796694.2.4.459. Future Oncol. 2006. PMID: 16922612 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters